Literature DB >> 11318596

Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection.

B Balasa1, B O Boehm, A Fortnagel, W Karges, K Van Gunst, N Jung, S A Camacho, S R Webb, N Sarvetnick.   

Abstract

The nonobese diabetic (NOD) mouse develops spontaneous T-cell-dependent autoimmune diabetes. We tested here whether vaccination of NOD mice with a plasmid DNA encoding glutamic acid decarboxylase (GAD), an initial target islet antigen of autoimmune T cell repertoire, would modulate their diabetes. Our results showed that vaccination of young or old female NOD mice with the GAD-plasmid DNA, but not control-plasmid DNA, effectively prevented their diabetes, demonstrating that GAD-plasmid DNA vaccination is quite effective in abrogating diabetes even after the development of insulitis. The prevention of diabetes did not follow the induction of immunoregulatory Th2 cells but was dependent upon CD28/B7 costimulation. Our results suggest a potential for treating spontaneous autoimmune diabetes via DNA vaccination with plasmids encoding self-Ag. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318596     DOI: 10.1006/clim.2001.5012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 3.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

4.  Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice.

Authors:  Yelena Glinka; Renée De Pooter; France Croze; Gérald J Prud'homme
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

Review 5.  Vaccine therapies for the prevention of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

7.  Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination.

Authors:  Katja Stifter; Cornelia Schuster; Michael Schlosser; Bernhard Otto Boehm; Reinhold Schirmbeck
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

8.  Role of immune system modulation in prevention of type 1 diabetes mellitus.

Authors:  Gamal Abdulrhman Hassan; Hamdy Ahmad Sliem; Abousree Taha Ellethy; Mahmoud El-Sawy Salama
Journal:  Indian J Endocrinol Metab       Date:  2012-11

Review 9.  Lessons for human diabetes from experimental mouse models.

Authors:  Rohit N Kulkarni; Ariel Zisman
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.